These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2534611)

  • 21. Growth hormone assessment by radioreceptor and radioimmunoassay. Radioreceptor assay and radioimmunoassay comparisons.
    LaFranchi S; Hanna CE; Jelen B
    Am J Dis Child; 1984 Jan; 138(1):23-7. PubMed ID: 6537873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sensitive, rapid, and economic radioimmunoassay of human growth hormone using ethanol-ammonium acetate.
    Saito T; Saxena BB
    J Lab Clin Med; 1975 Mar; 85(3):497-504. PubMed ID: 1167888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlative study of radioreceptor assay and radioimmunoassay of serum growth hormone in children. II: Primary, genetic and intra-uterine growth retardation.
    Garnier PE; Repellin AM; Job JC
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):227-38. PubMed ID: 580825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma prolactin in acromegaly before and after treatment.
    de Pablo F; Eastman RC; Roth J; Gorden P
    J Clin Endocrinol Metab; 1981 Aug; 53(2):344-52. PubMed ID: 7251817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avian growth hormone receptor assay: use of chicken and turkey liver membranes.
    Krishnan KA; Proudman JA; Bahr JM
    Mol Cell Endocrinol; 1989 Oct; 66(2):125-34. PubMed ID: 2612729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric forms.
    Baumann G; MacCart JG; Amburn K
    J Clin Endocrinol Metab; 1983 May; 56(5):946-52. PubMed ID: 6339541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations.
    Guyda JH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):953-67. PubMed ID: 1184726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth without growth hormone: the "invisible" GH syndrome.
    Bistritzer T; Chalew SA; Lovchik JC; Kowarski AA
    Lancet; 1988 Feb; 1(8581):321-3. PubMed ID: 2893137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancy between immunoactivity and bioactivity of big-big and big human growth hormones in acromegaly.
    Tanaka T; Aiba T; Shishiba Y
    Endocrinol Jpn; 1984 Apr; 31(2):133-40. PubMed ID: 6430686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parameters of human growth hormone (hGH) levels reflecting the activity of acromegaly].
    Jin ZM; Shi YF; Deng JY
    Zhonghua Nei Ke Za Zhi; 1987 May; 26(5):269-72, 318. PubMed ID: 3652832
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased circulating radioreceptor-active growth hormone in insulin-dependent diabetics.
    MacFarlane IA; Stafford SM; Wright AD
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):607-16. PubMed ID: 3621625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patients.
    Chiodini PG; Liuzzi A; Botalla L; Oppizzi G; Müller EE; Silvestrini F
    J Clin Endocrinol Metab; 1975 Apr; 40(4):705-8. PubMed ID: 1127079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values.
    Fogelman I; Hay ID; Citrin DL; Beastall GH; Turner JG; Bessent RG
    Br J Radiol; 1980 Sep; 53(633):874-7. PubMed ID: 7437709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian variation of basal plasma growth hormone in man.
    Drobny EC; Amburn K; Baumann G
    J Clin Endocrinol Metab; 1983 Sep; 57(3):524-8. PubMed ID: 6348063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of growth hormone and thyroid-stimulating hormone in cerebrospinal fluid and pathological compartments of the central nervous system.
    Schaub C; Bluet-Pajot MT; Szikla G; Lornet C; Talairach J
    J Neurol Sci; 1977; 31(1):123-31. PubMed ID: 833608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the biological activity of human growth hormone by enzyme linked immuno-receptor assay (ELIRA) method.
    Deezagi A; Mehrani M; Vaseli-Hagh N
    Immunol Invest; 2011; 40(4):427-45. PubMed ID: 21348636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone radiologand assay unresponsive to human prolactin.
    Etzrodt H; Musch KA; Schleyer M; Pfeiffer EF
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1184-7. PubMed ID: 932183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Measurement of urine human growth hormone levels by ultra-highly sensitive enzyme immunoassay].
    Hattori N; Kato Y; Murakami Y; Koshiyama H; Inoue T; Imura H
    Nihon Naibunpi Gakkai Zasshi; 1988 Feb; 64(2):78-92. PubMed ID: 3286300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A sandwich enzyme immunoassay of human growth hormone in serum using anti-human growth hormone IgG-beta-D-galactosidase conjugate.
    Yoshitake S; Endo Y; Nakagawa K; Imagawa M; Ohtaki S; Ishikawa E
    Clin Chim Acta; 1982 Oct; 125(1):1-7. PubMed ID: 6814792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.